Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medterra is a leading wellness company specializing in high-purity, hemp-derived cannabidiol (CBD) products, with a specific "Medterra Clinical" division focused on healthcare professionals. The company provides a range of THC-free formulations, including tinctures, capsules, and topicals, designed to address indications such as chronic pain, sleep disorders, and anxiety. Medterra distinguishes itself in the CBD market through a commitment to scientific rigor, utilizing third-party laboratory testing and participating in clinical research studies with academic institutions. Their products are distributed through a multi-channel strategy encompassing direct-to-consumer, retail, and professional medical networks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medterra Clinical.